ADA Scientific Sessions 2026 Abstract

IBI3042: A Novel Oral Once-Weekly Small-Molecule GLP-1 Receptor Agonist for Type 2 Diabetes and Obesity

By Ye Jiang, Jiali Ding, Yao Xiong, Shilan Liu, Decheng Ren

Experiments in animalsInterventions

The paper

Ye Jiang, Jiali Ding, Yao Xiong, Shilan Liu, Decheng Ren

Suzhou

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, poster 2543-P

doi.org/10.2337/db26-2543-p

Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity